What is an IP license, as a document rather than a process: a contract that grants permission and attaches conditions.
The permission is the easy part. One sentence grants the rights.
The conditions are the agreement, and they are where the money is. Two licences with identical royalty rates can differ tenfold in value depending on how the base, the field and the minimums are drafted.
A licence is not a sale. Ownership stays with the licensor throughout, along with the maintenance fees and the obligation to police everyone who has no licence.
Licence versus assignment
| Licence | Assignment | |
|---|---|---|
| Ownership | Stays with licensor | Transfers |
| Duration | Defined term | Permanent |
| Licensor can still practise | Unless exclusive | No, without a licence back |
| Recording with USPTO | Advisable | Required within 3 months |
| Reversible | On termination | No |
| Maintenance fees | Licensor's | Buyer's |
An assignment with no licence back is absolute. Sellers occasionally discover after closing that they can no longer practise their own invention, because nobody wrote in a reservation.
The clauses that decide the value
Identification of the licensed rights
Name the patents by number. "All intellectual property relating to X" is the most common serious defect in a licence, and it produces disputes about scope years later when the parties have changed personnel.
| Include | Because |
|---|---|
| Patent and application numbers | Precision |
| Continuations, divisionals, foreign counterparts | Otherwise the family is not covered |
| Future family members | New continuations should not need a new agreement |
| Know-how, if any | Can outlive the patent legitimately |
Scope: field of use and territory
Field of use is the licensor's most valuable drafting tool. A patent licensed exclusively for one application can still be licensed exclusively for others.
| Licence structure | Total achievable revenue |
|---|---|
| One exclusive licence, all fields | One payment stream |
| Exclusive per field across four fields | Four payment streams |
Territory matters because rights are national. A US patent grants nothing abroad. A worldwide licence on a US-only patent gives the licensee very little they did not already have outside the US — and gives away the ability to license in markets where you may later obtain rights.
Exclusivity
| Type | Who may practise | Rate |
|---|---|---|
| Non-exclusive | Licensee, licensor, and any other licensee | Lowest |
| Sole | Licensee and licensor only | Middle |
| Exclusive | Licensee only — licensor excluded | Highest |
Exclusive normally excludes the licensor too. If you intend to keep practising, you need a sole licence or an express reservation.
An exclusive licensee of all substantial rights may sue infringers in their own name, which is a significant consequence. Where exclusivity is partial, the licensor usually needs to be joined.
Payment: base before rate
The royalty base is the revenue figure the percentage applies to, and it decides more than the percentage does.
| Structure | Rate | Base | Annual on 100,000 units |
|---|---|---|---|
| Finished product | 5% | $500 | $2,500,000 |
| Covered component | 5% | $20 | $100,000 |
Define net sales exhaustively. List every permitted deduction — returns, freight, insurance, taxes, trade discounts. An open-ended deduction clause lets a licensee reduce royalties substantially while complying with the contract.
Address combination products. Where the licensed technology is one part of a larger offering, the apportionment method needs to be in the document rather than argued about later.
Minimum annual royalties
Essential in any exclusive licence. Without them, a licensee can take exclusive rights, shelve the technology, and pay nothing for the rest of the term — a common outcome when a licensee's real motive is to keep the technology away from competitors.
| Protection | Effect |
|---|---|
| Minimum annual royalty | Floor regardless of sales |
| Diligence obligations | Licensee must actively commercialise |
| Milestone dates | Specific development or launch deadlines |
| Conversion to non-exclusive | Exclusivity lapses if minimums are missed |
Conversion is the most elegant remedy. Rather than terminating, exclusivity simply drops to non-exclusive if the licensee underperforms, freeing you to license others without litigation.
Reporting and audit
A royalty is a percentage of a number the licensee calculates. Verification rights are what make it real.
Set a variance threshold that shifts audit costs. Standard practice is that the licensor pays for the audit unless under-reporting exceeds a stated percentage, commonly 5%, at which point the licensee pays.
Improvements and grant-backs
| Arrangement | Enforceability |
|---|---|
| Licensee owns its improvements | Standard |
| Non-exclusive grant-back to licensor | Common, generally acceptable |
| Exclusive grant-back | Attracts competition law scrutiny; may be unenforceable |
| Assignment of improvements to licensor | Aggressive; often resisted and sometimes unlawful |
Silence on improvements causes disputes. If the licensee develops a better version, who owns it, and can they use it after termination?
Warranties, indemnities, termination
Warrant ownership and authority. Resist warranting validity. No licensor can guarantee a patent survives challenge, and warranting it transfers a risk you cannot price.
Do not warrant non-infringement of third-party rights. A patent grants a right to exclude, not a right to practise. Freedom to operate is the licensee's problem, and saying so plainly in the agreement is standard.
Termination should cover material breach with a cure period, insolvency, challenge to validity, and what happens to remaining inventory and any sublicences already granted.
Worked example: two drafts, same rate
A patent covering a filtration membrane. Both drafts say 5%.
Draft A — licensee's version
| Clause | As drafted |
|---|---|
| Licensed rights | "The Patent and related intellectual property" |
| Field | All fields |
| Territory | Worldwide |
| Exclusivity | Exclusive |
| Base | Net sales of the membrane component, $30 |
| Deductions | "Customary deductions" |
| Minimum annual | None |
| Improvements | Licensee owns; no grant-back |
| Warranties | Licensor warrants validity and non-infringement |
Draft B — licensor's version
| Clause | As drafted |
|---|---|
| Licensed rights | Patent numbers listed, plus continuations and foreign counterparts |
| Field | Water treatment only |
| Territory | US and EU, where rights exist |
| Exclusivity | Exclusive in field; converts to non-exclusive if minimums missed |
| Base | Net sales of the filtration module, $260 |
| Deductions | Enumerated: returns, freight, insurance, sales taxes |
| Minimum annual | $80,000 from year two |
| Improvements | Licensee owns; non-exclusive grant-back |
| Warranties | Ownership and authority only |
What the difference is worth
| Draft A | Draft B | |
|---|---|---|
| Rate | 5% | 5% |
| Base per unit | $30 | $260 |
| Royalty at 40,000 units | $60,000 | $520,000 |
| Other fields licensable | No | Yes — medical, industrial, food |
| Protected if licensee stalls | No | Minimums plus conversion |
| Validity risk | Licensor's | Licensee's |
Nearly nine times the revenue at the same headline rate, plus three further fields left free to license, plus the validity risk left where it belongs.
Draft A is not unusual. It is what a first draft from a licensee's counsel routinely looks like, and a licensor who negotiates only the percentage will accept most of it.
Terms with legal limits
| Term | Limit |
|---|---|
| Royalties past patent expiry | Patent misuse — Brulotte v. Thys, Kimble v. Marvel |
| Exclusive grant-backs | Competition law scrutiny, US and EU |
| Tying to unpatented products | Potential misuse |
| No-challenge clauses | Often unenforceable; Lear v. Adkins |
| Resale price maintenance | Antitrust exposure |
The expiry rule is the one that catches ordinary agreements. A royalty tied to a single expired patent is unenforceable. Multi-patent deals with staggered expiry, and know-how with independent value, can continue — but only if the agreement separates the components rather than charging one blended rate.
No-challenge clauses rarely work. A licensee generally retains the right to challenge validity regardless of what the agreement says, though it may permit termination or a rate increase if they do.
What the licence leaves you holding
Signing does not end your obligations. You still own the patent.
| Continuing obligation | Cost |
|---|---|
| Maintenance fees | $2,150 / $4,040 / $8,280 — $14,470 total, large entity |
| Enforcement against non-licensees | Yours |
| Validity defence | Yours |
| Royalty monitoring and audits | Yours |
Run the arithmetic before signing. A licence generating $40,000 a year against an approaching $8,280 fee plus monitoring costs is thinner than the headline suggests, and 58.6% of US utility patents are abandoned precisely because that arithmetic stops working. See the patent survival curve.
Compare it against selling. A sale ends every row in that table for one payment. See patents for sale and what is IP licensing for the process side.
Reading a licence you have been offered
A first draft from the other side is written for the other side. These are the clauses to find before anything else.
| Find | Read it for |
|---|---|
| Grant clause | Is the scope wider than what they need? |
| Royalty base definition | Which revenue figure, and is it the smallest unit? |
| Deductions | Enumerated, or open-ended? |
| Exclusivity | Does it exclude you from your own technology? |
| Term | Does it outlast the patent? Do royalties stop at expiry? |
| Improvements | Who owns what they build on top? |
| Warranties | Are you warranting validity or non-infringement? |
| Termination | Can they exit easily while you cannot? |
| Assignment | Can they transfer the licence to a competitor of yours? |
The assignment clause is routinely overlooked. A licence freely assignable by the licensee can end up held by a company you would never have licensed — including, after an acquisition, a direct competitor.
Change of control deserves its own provision. A licensee acquired by a larger group may bring the licensed technology into a much bigger operation, multiplying use without any increase in payment. Either restrict assignment, or price the change-of-control scenario at signing.
Check for most-favoured-nation clauses. A clause promising this licensee terms no worse than any future licensee constrains every deal you sign afterwards, and its effect compounds silently across a licensing programme.
IP licence agreement: the checklist
- List the licensed rights by number, including continuations, divisionals and foreign counterparts. Never "all IP relating to."
- Restrict the field of use so the same asset can be licensed again elsewhere.
- Limit territory to where rights actually exist. Licensing worldwide on a US-only patent gives away future markets for nothing.
- State whether exclusivity excludes the licensor. If you intend to keep practising, take a sole licence or reserve the right expressly.
- Define the royalty base before negotiating the rate. It is usually worth more than the percentage.
- Enumerate permitted deductions. "Customary deductions" is an open door.
- Include minimum annual royalties in any exclusive licence, with conversion to non-exclusive as the remedy for missing them.
- Take audit rights with a variance threshold that shifts costs to the licensee when they have under-reported.
- Warrant ownership and authority only. Refuse to warrant validity or non-infringement.
- End patent royalties at expiry, and separate any know-how or multi-patent components that are intended to continue.